Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
Published by: Science Advances – April 27, 2022 Abstract Multiple sclerosis (MS) is an inflammatory disease of the central nervous…
Prevalence of MS Among Black People ‘Under-recognized’: Study
by Lindsey Shapiro PhD | May 5, 2022 Rates of multiple sclerosis (MS) were similar among Black and white people, but significantly lower…
Stuart Schlossman
Four new autoantigens trigger multiple sclerosis
Swiss and Swedish researchers have uncovered four previously unknown autoantigens that trigger multiple sclerosis in mice. April 27, 2022 Article…
Stuart Schlossman
MS Living Well Podcast: Multiple Sclerosis Biomarkers including Blood Tests – an interview led by Barry Singer, MD
April 26, 2022 Photo: Rawpixel Rapid recent advancements have led to blood tests (biomarkers) to track multiple sclerosis disease activity.…
Stuart Schlossman
8 More SPMS Patients Cleared for Foralumab Nasal Spray Treatment
by Marta Figueiredo PhD | April 12, 2022 BREAKING NEWS Based on findings from the first two secondary progressive multiple sclerosis (SPMS)…
Stuart Schlossman
Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
ABSTRACT Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system characterized by broad inter-…
Stuart Schlossman
MS researchers in Buffalo and Boston join forces to understand the most severe, and humbling, cases
April 21, 2022 Scott Scanlon Multiple sclerosis robbed Mary Jo Montani of many abilities late in life. She could barely…
Stuart Schlossman
New Study Confirms the High Costs of MS to Individuals and the U.S. Economy — (“The Economic Burden of Multiple Sclerosis in the U.S.”)
April 13, 2022 A new study, commissioned by the National MS Society, shows that for the nearly 1 million people…
Stuart Schlossman
New Research Finds That, For The First Time Ever, Stem Cell Treatments Improve Disability Status for Multiple Sclerosis Patients With Progressive Disease
Preliminary analysis of FDA-approved study conducted by the Tisch MS Research Centerof New York found that stem cell treatments substantially improved…
Stuart Schlossman
“Never Drinking Alcohol” Tied to ‘Significantly’ Higher MS Risk
Not drinking alcohol significantly increases the risk of developing multiple sclerosis (MS), especially if a person also is a current or former…
Stuart Schlossman
